Pharmacology
 |
|
21 august 2017 17:58:02 |
| Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes (Pharmacogenomics Journal) |
|
Tweet |
| 155 viewsCategory: Genomics, Pharmacology |
 The CYP2D6 VCF Translator (Pharmacogenomics Journal)Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
